Skip to main content

Marizyme

  • About
      • Back
      • Overview
      • Executive Management
      • Board of Directors
      • Corporate Governance
  • Products
      • Back
      • Overview
      • DuraGraft®
      • Krillase®
      • MATLOC™ Platform
  • Investors
  • Contact
      • Back
      • Contact Us
  • Sign Up
adobe stock 229690447

About
Overview

 

About Us

Marizyme, Inc. is a multi-technology biomedical company dedicated to the development and commercialization of medical technologies that improve patient health outcomes.

Our healthcare innovations address critical market gaps and offer transformative potential to wide range of indications including:

 

path 2059 group 4601 path 2058
Coronary Artery Bypass Graft Surgery Pet Health Chronic Kidney Disease

 

Innovative

Marizyme's products seek to dramatically improve some of the world’s most prevalent and costly healthcare challenges.

 

group 4608
Industry Leading

Marizyme seeks to leverage its full suite of biomedical assets to dramatically improve patient outcomes for some of the world’s most prevalent and costly healthcare challenges.

group 4610
Diverse

With one flagship product and multiple pipeline products and technologies, Marizyme presents opportunity while accounting for risk.

group 4609
Opportunity

Led by a world-class management team, Marizyme continues to execute on its milestones and deliver both patient and shareholder value.


LEARN MORE

 

Marizyme, Inc. is a multi-technology biomedical company dedicated to the development and commercialization of medical technologies that improve patient health outcomes.

 

Investors

  • Stock Info
  • SEC Filings
  • Corporate Governance

Contact

  • Back
  • Contact Us
  • Sign Up
  • Accessibility
 

Get In Touch 

noun map 223137 555 Heritage Drive, Ste. 205,
Jupiter, FL 33458
noun phone 4637987 (561) 935-9955
noun email 3083073 info@marizyme.com 
Marizyme
© Copyright - 2023 Marizyme Inc. | All Rights Reserved | Website by Sandman Media Inc